David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
1001
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.19M | 0.01% |
+32,570
| New | +$7.05M |
|
|
AET
1002
CALL
DELISTED
Aetna Inc
AET
| $9.18M | 0.01% |
86,200
-99,400
| -54% | -$9.74M |
|
|
PRA
1003
DELISTED
ProAssurance
PRA
| $9.18M | 0.01% |
199,942
+101,838
| +104% | +$4.63M |
|
|
ARC
1004
DELISTED
ARC Document Solutions, Inc.
ARC
| $9.17M | 0.01% |
993,320
-88,467
| -8% | -$804K |
|
|
BHI
1005
PUT
DELISTED
Baker Hughes
BHI
| $9.15M | 0.01% |
143,900
-176,900
| -55% | -$10.7M |
|
|
TWX
1006
PUT
DELISTED
Time Warner Inc
TWX
| $9.12M | 0.01% |
108,000
-223,300
| -67% | -$18.6M |
|
|
LQ
1007
DELISTED
La Quinta Holdings Inc.
LQ
| $9.08M | 0.01% |
383,366
+53,828
| +16% | +$1.19M |
|
1008
Benchmark Electronics
BHE
$2.59B
| $9.07M | 0.01% |
377,371
+104,245
| +38% | +$2.49M |
|
|
SLH
1009
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $9.06M | 0.01% |
175,353
-163,770
| -48% | -$8.64M |
|
1010
Bank of Montreal
BMO
$121B
| $9.03M | 0.01% |
150,668
-46,351
| -24% | -$2.87M |
|
|
TIF
1011
CALL
DELISTED
Tiffany & Co.
TIF
| $9.02M | 0.01% |
102,500
-22,700
| -18% | -$2.03M |
|
|
CLDT
1012
Chatham Lodging
CLDT
$644M
| $9.02M | 0.01% |
306,561
-49,388
| -14% | -$1.48M |
|
|
CRR
1013
DELISTED
Carbo Ceramics Inc.
CRR
| $9M | 0.01% |
294,946
+227,182
| +335% | +$7.97M |
|
1014
ConocoPhillips
COP
$158B
| $8.98M | 0.01% |
144,231
-252,163
| -64% | -$16.3M |
|
1015
PUT
Stryker
SYK
$125B
| $8.97M | 0.01% |
97,200
-76,600
| -44% | -$7.13M |
|
|
CSII
1016
DELISTED
Cardiovascular Systems, Inc.
CSII
| $8.96M | 0.01% |
229,639
+89,755
| +64% | +$3.09M |
|
|
WMGI
1017
DELISTED
Wright Medical Group Inc
WMGI
| $8.96M | 0.01% |
347,280
+126,629
| +57% | +$3.26M |
|
1018
CALL
F5
FFIV
$21.8B
| $8.94M | 0.01% |
77,800
-10,700
| -12% | -$1.26M |
|
|
SNDK
1019
CALL
DELISTED
SANDISK CORP
SNDK
| $8.94M | 0.01% |
140,500
-262,700
| -65% | -$21.3M |
|
1020
Welltower
WELL
$173B
| $8.93M | 0.01% |
115,490
+57,608
| +100% | +$4.53M |
|
1021
FerroAtlántica
GSM
$749M
| $8.93M | 0.01% |
471,884
+165,759
| +54% | +$2.8M |
|
1022
Angi Inc
ANGI
$204M
| $8.91M | 0.01% |
151,733
+73,287
| +93% | +$4.33M |
|
1023
SBA Communications
SBAC
$19.6B
| $8.9M | 0.01% |
75,966
+67,331
| +780% | +$7.95M |
|
|
SFR
1024
DELISTED
Starwood Waypoint Homes
SFR
| $8.88M | 0.01% |
343,642
-306,047
| -47% | -$7.73M |
|
|
CIM
1025
Chimera Investment
CIM
$968M
| $8.84M | 0.01% |
187,743
-54,317
| -22% | -$2.6M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.